Hass, R. Role of MSC in the tumor microenvironment. Cancers 12, 2107 (2020).
Article CAS PubMed PubMed Central Google Scholar
Li, C., Zhao, H. & Wang, B. Mesenchymal stem/stromal cells: developmental origin, tumorigenesis and translational cancer therapeutics. Transl. Oncol. 14, 100948 (2021).
Article CAS PubMed Google Scholar
Rennert, R. C., Sorkin, M., Garg, R. K. & Gurtner, G. C. Stem cell recruitment after injury: lessons for regenerative medicine. Regen. Med. 7, 833–850 (2012).
Article CAS PubMed PubMed Central Google Scholar
Sordi, V. Mesenchymal stem cell homing capacity. Transplantation 87, S42–S45 (2009).
Klopp, A. H. et al. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res. 67, 11687–11695 (2007).
Article CAS PubMed PubMed Central Google Scholar
Kidd, S. et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27, 2614–2623 (2009). This study demonstrates the mobility and adaptability of MSCs to numerous sites in response to various types of injuries.
Article CAS PubMed PubMed Central Google Scholar
Guo, Y.-C., Chiu, Y.-H., Chen, C.-P. & Wang, H.-S. Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration. Stem Cell Res. Ther. 9, 281 (2018).
Article CAS PubMed PubMed Central Google Scholar
Hocking, A. M. The role of chemokines in mesenchymal stem cell homing to wounds. Adv. Wound Care 4, 623–630 (2015).
Kucia, M. et al. The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner. Arch. Immunol. Ther. Exp. 54, 121–135 (2006).
Ishikawa, M. et al. MCP/CCR2 signaling is essential for recruitment of mesenchymal progenitor cells during the early phase of fracture healing. PLoS ONE 9, e104954 (2014).
Article PubMed PubMed Central Google Scholar
Liu, L. et al. From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? Stem Cells Int. 2013, 435093 (2013).
Article PubMed PubMed Central Google Scholar
Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315–317 (2006). This foundational paper defines the minimum criteria needed to isolate and manage MSC primary cell lines.
Article CAS PubMed Google Scholar
Viswanathan, S. et al. Mesenchymal stem versus stromal cells: international society for cell and gene therapy (ISCT) mesenchymal stromal cell committee position statement on nomenclature. Cytotherapy 21, 1019–1024 (2019).
Article CAS PubMed Google Scholar
Rustad, K. C. & Gurtner, G. C. Mesenchymal stem cells home to sites of injury and inflammation. Adv. Wound Care 1, 147–152 (2012).
Zhu, M. et al. Orchestration of mesenchymal stem/stromal cells and inflammation during wound healing. Stem Cells Transl. Med. 12, 576–587 (2023).
Article CAS PubMed PubMed Central Google Scholar
Ahangar, P., Mills, S. J. & Cowin, A. J. Mesenchymal stem cell secretome as an emerging cell-free alternative for improving wound repair. Int. J. Mol. Sci. 21, 7038 (2020).
Article CAS PubMed PubMed Central Google Scholar
Chen, Y. et al. Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver. J. Cell. Mol. Med. 14, 1494–1508 (2010).
Hamou, C. et al. Mesenchymal stem cells can participate in ischemic neovascularization. Plast. Reconstr. Surg. 123, 45S–55S (2009).
Article CAS PubMed PubMed Central Google Scholar
Moustakas, A. & Heldin, C.-H. Mechanisms of TGFβ-Induced epithelial-mesenchymal transition. J. Clin. Med. 5, 63 (2016).
Article PubMed PubMed Central Google Scholar
Xu, J., Lamouille, S. & Derynck, R. TGF-β-induced epithelial to mesenchymal transition. Cell Res. 19, 156–172 (2009).
Article CAS PubMed PubMed Central Google Scholar
Song, Y. et al. Emerging role of mesenchymal stromal cells in gynecologic cancer therapy. Stem Cell Res. Ther. 14, 347 (2023).
Article PubMed PubMed Central Google Scholar
Nitzsche, F. et al. Concise review: MSC adhesion cascade-insights into homing and transendothelial migration. Stem Cells 35, 1446–1460 (2017).
Walewska, A., Janucik, A., Tynecka, M., Moniuszko, M. & Eljaszewicz, A. Mesenchymal stem cells under epigenetic control — the role of epigenetic machinery in fate decision and functional properties. Cell Death Dis. 14, 720 (2023).
Article CAS PubMed PubMed Central Google Scholar
Reinisch, A. et al. Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. Blood 125, 249–260 (2015).
Article CAS PubMed Google Scholar
Kim, M. & Costello, J. DNA methylation: an epigenetic mark of cellular memory. Exp. Mol. Med. 49, e322 (2017).
Article CAS PubMed PubMed Central Google Scholar
Stavely, R. & Nurgali, K. The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl. Med. 9, 985–1006 (2020).
Article PubMed PubMed Central Google Scholar
Sai, B. et al. Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs. Cell Death Dis. 10, 941 (2019).
Article CAS PubMed PubMed Central Google Scholar
Mader, E. K. et al. Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model. Clin. Cancer Res. 15, 7246–7255 (2009).
Article CAS PubMed PubMed Central Google Scholar
Chang, D.-Y. et al. The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase. Int. J. Cancer 127, 1975–1983 (2010).
Article CAS PubMed Google Scholar
Mader, E. K. et al. Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer. J. Transl. Med. 11, 20 (2013).
Article CAS PubMed PubMed Central Google Scholar
Liu, Y., Zhao, J., Jiang, J., Chen, F. & Fang, X. Doxorubicin delivered using nanoparticles camouflaged with mesenchymal stem cell membranes to treat colon cancer. Int. J. Nanomedicine 15, 2873–2884 (2020).
Comments (0)